Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Transgenic mouse having a genome comprising a homozygous disruption of the endogenous MFN2 gene expression in the dopaminergic neurons

Transgenic mouse having a genome comprising a homozygous disruption of the endogenous MFN2 gene expression in the dopaminergic neurons

US Patent 9456588 · Granted Oct 4, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cosmetic composition that resists pilling2025
Cosmetic composition comprising natural emulsifiers and thiopyridinone compounds2025
Cosmetic composition containing a rheological-modifying and stabilizing polymer 2025
Cosmetic composition comprising high amounts of ceramide-np2024
Low viscosity emulsion cosmetic composition2024
Cosmetic compositions having stabilized retinol2024
Rat models for CMT2A that develop a progressive neuropathy2023
Masked face recognition method2023
Cosmetic composition for improved penetration2022
Skin-tightening composition2021
Stabilized cosmetic compositions2021
Synergistic blend of natural oils with apple cider vinegar for make-up removal2021